Pouring cold water on ALS progression: novel drug shields neurons from damage
Original story from the University of Arizona (AZ, USA). An experimental drug that targets the TDP-43 protein offers hope for treating Amyotrophic Lateral Sclerosis (ALS), a condition that still…
Read the full articleYou might also wanna read
UCSD gene therapy preserves brain function by boosting protective protein rather than removing toxic TDP-43
UCSD study says the therapy increased expression of a neuroprotective protein to help preserve brain functions, despite the presence of a de
sandiegouniontribune.com·1mo ago
Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice - Nature Aging
A study in Nature Aging identifies a region of the ALS-linked protein TDP-43 and shows that a brain-penetrant small molecule targeting this
Short RNA chaperones inhibit TDP-43 aggregation to reduce neurodegeneration in ALS models
Aberrant aggregation of the prion-like RNA binding protein TDP-43 drives several fatal neurodegenerative proteinopathies, including amyotrop
doi.org·1mo ago
Caspase-4 transgenic mice exhibit cytoplasmic TDP-43 accumulation and age-dependent neuropathology
Caspase-4 transgenic mice show cytoplasmic TDP-43 accumulation, crucial for studying ALS. This model solves previous limitations, unlocking
ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026
PMN310 demonstrated dose-dependent reduction of amyloid-beta oligomers in human cerebrospinal fluid following a single dose in healthy volun
Exploring Intracellular Communication to Understand Neurodegeneration
Investigators have uncovered a new communication pathway between mitochondria and RNA granules that may improve the understanding of how the
Comments
Sign in to join the conversation.
No comments yet. Be the first.